These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2429863)

  • 21. Characterization of membrane permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin.
    McClane BA; McDonel JL
    Biochim Biophys Acta; 1980 Aug; 600(3):974-85. PubMed ID: 6157413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production, purification, and assay of Clostridium perfringens enterotoxin.
    McDonel JL; McClane BA
    Methods Enzymol; 1988; 165():94-103. PubMed ID: 2906731
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of a Clostridium perfringens 8-6 enterotoxin on viability and macromolecular synthesis in Vero cells.
    Lindsay JA
    Biochem Biophys Res Commun; 1988 Mar; 151(3):1371-7. PubMed ID: 2451521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium-independent and dependent steps in action of Clostridium perfringens enterotoxin on HeLa and Vero cells.
    Matsuda M; Sugimoto N
    Biochem Biophys Res Commun; 1979 Nov; 91(2):629-36. PubMed ID: 229852
    [No Abstract]   [Full Text] [Related]  

  • 25. Enterotoxin formation by Clostridium perfringens type A studied by the use of fluorescent antibody.
    Niilo L
    Can J Microbiol; 1977 Jul; 23(7):908-15. PubMed ID: 195700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitrate salts suppress sporulation and production of enterotoxin in Clostridium perfringens strain NCTC8239.
    Yasugi M; Otsuka K; Miyake M
    Microbiol Immunol; 2016 Oct; 60(10):657-668. PubMed ID: 27594514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly sensitive assay for Clostridium perfringens enterotoxin that uses inhibition of plating efficiency of Vero cells grown in culture.
    McDonel JL; McClane BA
    J Clin Microbiol; 1981 May; 13(5):940-6. PubMed ID: 6263946
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of Clostridium perfringens enterotoxin in stool specimens and culture supernatants by enzyme-linked immunosorbent assay.
    Wimsatt JC; Harmon SM; Shah DB
    Diagn Microbiol Infect Dis; 1986 Apr; 4(4):307-13. PubMed ID: 2870839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The complex interactions between Clostridium perfringens enterotoxin and epithelial tight junctions.
    McClane BA
    Toxicon; 2001 Nov; 39(11):1781-91. PubMed ID: 11595640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Osmotic stabilizers differentially inhibit permeability alterations induced in Vero cells by Clostridium perfringens enterotoxin.
    McClane BA
    Biochim Biophys Acta; 1984 Oct; 777(1):99-106. PubMed ID: 6487622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding of Clostridium perfringens [125I]enterotoxin to rabbit intestinal cells.
    McDonel JL
    Biochemistry; 1980 Oct; 19(21):4801-7. PubMed ID: 6252960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chymotrypsin treatment increases the activity of Clostridium perfringens enterotoxin.
    Granum PE; Richardson M
    Toxicon; 1991; 29(7):898-900. PubMed ID: 1926189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clostridium perfringens type A enterotoxin induces release of noradrenaline from the neurosecretory PC12 cell line.
    Ozutsumi K; Sugimoto N; Matsuda M
    Biochem Biophys Res Commun; 1987 Apr; 144(1):217-23. PubMed ID: 3579904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of enterotoxigenic Clostridium perfringens in healthy humans in relation to the enhancement of enterotoxin production by heat treatment.
    Uemura T
    J Appl Bacteriol; 1978 Jun; 44(3):411-9. PubMed ID: 209009
    [No Abstract]   [Full Text] [Related]  

  • 35. Intracellular antibody against Clostridium perfringens enterotoxin fails to counteract toxin-induced damage.
    Petrie HT; McDonel JL; Schlegel RA
    Cell Biol Int Rep; 1982 Jul; 6(7):705-11. PubMed ID: 6290086
    [No Abstract]   [Full Text] [Related]  

  • 36. Quantitation of binding and subcellular distribution of Clostridium perfringens enterotoxin in rat liver cells.
    Tolleshaug H; Skjelkvåle R; Berg T
    Infect Immun; 1982 Aug; 37(2):486-91. PubMed ID: 6288564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Identification of enterotoxin-producing Clostridium perfringens by the polymerase chain reaction].
    Kato N; Kim SM; Kato H; Tanaka K; Watanabe K; Ueno K; Chong Y
    Kansenshogaku Zasshi; 1993 Aug; 67(8):724-9. PubMed ID: 8409580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clostridium perfringens enterotoxin damages the human intestine in vitro.
    Fernández Miyakawa ME; Pistone Creydt V; Uzal FA; McClane BA; Ibarra C
    Infect Immun; 2005 Dec; 73(12):8407-10. PubMed ID: 16299340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clostridium perfringens enterotoxin acts by producing small molecule permeability alterations in plasma membranes.
    McClane BA
    Toxicology; 1994 Feb; 87(1-3):43-67. PubMed ID: 8160188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The enterotoxin of Clostridium perfringens type A binds to the presynaptic nerve endings in neuromuscular junctions of mouse phrenic nerve-diaphragm.
    Senda T; Sugimoto N; Horiguchi Y; Matsuda M
    Toxicon; 1995 Apr; 33(4):499-506. PubMed ID: 7570635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.